Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Rhea-AI Summary

Avid Bioservices (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization, has announced its participation in the upcoming Craig-Hallum Bioprocessing Conference. The virtual event is scheduled for September 19, 2024.

Key highlights:

• President and CEO Nick Green and VP of Process Development Pramthesh Patel, Ph.D., will be featured speakers
• The fireside chat is set for 2:45 p.m. Eastern on the conference day
• A webcast replay will be available on Avid's investor website after the event

This participation underscores Avid Bioservices' commitment to engaging with industry stakeholders and showcasing its expertise in biologics manufacturing and development services.

TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the upcoming Craig-Hallum Bioprocessing Conference. Nick Green, president and chief executive officer, and Pramthesh Patel, Ph.D., vice president of process development, will be the featured speakers in a fireside chat at the conference, which will take place virtually on September 19, 2024.

Details of the company’s participation are as follows:

• Craig-Hallum Bioprocessing Conference
  Details: Mr. Green and Dr. Patel will participate in a fireside chat
  Conference Date: September 19, 2024
  Fireside Chat Timing: 2:45 p.m. Eastern on Thursday, September 19, 2024
  Format: Virtual

Following the fireside chat, a webcast replay will be available via a link on Avid’s investor website at: http://ir.avidbio.com/investor-events.

About Avid Bioservices, Inc. 

Avid Bioservices (NASDAQ: CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

FAQ

When is Avid Bioservices (CDMO) participating in the Craig-Hallum Bioprocessing Conference?

Avid Bioservices (CDMO) is participating in the Craig-Hallum Bioprocessing Conference on September 19, 2024. The company's fireside chat is scheduled for 2:45 p.m. Eastern on that day.

Who will be representing Avid Bioservices (CDMO) at the Craig-Hallum Bioprocessing Conference?

Nick Green, President and CEO, and Pramthesh Patel, Ph.D., Vice President of Process Development, will be representing Avid Bioservices (CDMO) at the Craig-Hallum Bioprocessing Conference.

Is the Craig-Hallum Bioprocessing Conference featuring Avid Bioservices (CDMO) an in-person or virtual event?

The Craig-Hallum Bioprocessing Conference featuring Avid Bioservices (CDMO) is a virtual event.

How can investors access the replay of Avid Bioservices' (CDMO) fireside chat at the Craig-Hallum Conference?

Investors can access the replay of Avid Bioservices' (CDMO) fireside chat through a webcast link available on the company's investor website at http://ir.avidbio.com/investor-events after the event.